The global digital therapeutics (DTx) market is expected to grow from USD 3.01 billion in 2019 to USD 13.83 billion by 2027, at a CAGR of 21% during the forecast period 2020-2027.
Digital therapeutics (DTx) is used in evidence-based therapies by using software through mobile health applications. It replaces the traditional treatment of diseases. Digital therapeutic is mainly used in the treatment of chronic diseases, along with prevention and management. Digital therapeutic is based on a collection of digital data related to lifestyle and behavioural changes. Data is collected with digital methodology in order to track the progress and take preventive measures. It is supported by rigorous clinical evidence to consider a broad spectrum of behavioural, physical and mental conditions. The global digital therapeutics (DTx) market is driven by an increased adoption of tablets, smartphones and gadgets. Also, a rise in chronic diseases along with a rise in the cost of healthcare is generating the demand for digital therapeutics (DTx) market.
This study delivers a comprehensive analysis of applications, sales channels and regions.
The application segment includes gastrointestinal disorder, smoking cessation, respiratory disease, central nervous system disease, cardiovascular disease, obesity and diabetes. The obesity segment has the largest share in the digital therapeutics (DTx) market and is expected to show higher growth over the forecast period. It is due to an increased number of diseases related to obesity, along with an increased number of overweight people. Better accessibility of digital therapeutics results in maintaining proper diet and tracking physical activities. It also provides online assistance in the prevalence of obesity.
The sales channel segment includes business-to-consumer and business-to-business. Business-to-consumer is further divided into caregivers and patients. Business-to-business is further divided into Pharmaceutical Companies, Employers, Payers and Providers. The caregivers has mainly contributed to the growth of the business-to-consumer segment, and it is expected to show the highest growth in the forecast period. Better management of patients is done with the help of digital therapeutics, which results in supporting caregivers in healthcare systems.
The market has been divided into North America, Europe, Asia-Pacific, Middle East & Africa, and South America. North-America has the largest share of digital therapeutics (DTx) market due to rise in the chronic diseases, increase in geriatric population, availability of sophisticated reimbursement structure and increase in demand for portable & wireless systems. The influx of start-ups are also contributing in the growth of the market.
Some of the notable players in the digital therapeutics (DTx) market are Livongo Health, WellDoc, Proteus Digital Health, Akili Interactive Labs, Happify, Mango Health, Canary Health, Cognoa, Mindstrong Health, Ginger, Noom, Pear Therapeutics, Better Therapeutics, Click Therapeutics, Ayogo Health, Omada Health, Propeller Health, Kaia Health, Wellthy Therapeutics and 2Morrow. Omada Health is hugely investing in digital therapeutics to enhance its solution in digital pre-diabetes field. Company is also investing in research and developments in the area of digital healthcare programs. Omada has also launched the mHealth Platform for depression and anxiety.
This study forecasts revenue growth at global, regional, and country levels from 2020 to 2027. Fior Markets has segmented the market based on below-mentioned segments:
Global Digital Therapeutic (DTx) Market Analysis And Forecast, By Application
Global Digital Therapeutic (DTx) Market Analysis And Forecast, By Sales Channel
Global Digital Therapeutic (DTx) Market Analysis And Forecast, By Regional Analysis
1. Introduction
1.1. Objectives of the Study
1.2. Market Definition
1.3. Research Scope
1.4. Currency
1.5. Key Target Audience
2. Research Methodology and Assumptions
3. Executive Summary
4. Premium Insights
4.1. Porter’s Five Forces Analysis
4.2. Value Chain Analysis
4.3. Top Investment Pockets
4.3.1. Market Attractiveness Analysis By Application
4.3.2. Market Attractiveness Analysis By Sales Channel
4.3.3. Market Attractiveness Analysis By Region
4.4. Industry Trends
5. Market Dynamics
5.1. Market Evaluation
5.2. Drivers
5.3. Restraints
5.4. Opportunities
5.5. Challenges
6. Global Digital Therapeutic (DTx) Market Analysis and Forecast, By Application
6.1. Segment Overview
6.2. Gastrointestinal Disorder
6.3. Smoking Cessation
6.4. Respiratory Disease
6.5. Central Nervous System Disease
6.6. Cardiovascular Disease
6.7. Obesity
6.8. Diabetes
7. Global Digital Therapeutic (DTx) Market Analysis and Forecast, By Sales Channel
7.1. Segment Overview
7.2. Business-to-Consumer
7.3. Business-to-Business
8. Global Digital Therapeutic (DTx) Market Analysis and Forecast, By Regional Analysis
8.1. Segment Overview
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.2.3. Mexico
8.3. Europe
8.3.1. Germany
8.3.2. France
8.3.3. U.K.
8.3.4. Italy
8.3.5. Spain
8.4. Asia-Pacific
8.4.1. Japan
8.4.2. China
8.4.3. India
8.5. South America
8.5.1. Brazil
8.6. Middle East and Africa
8.6.1. UAE
8.6.2. South Africa
9. Global Digital Therapeutic (DTx) Market-Competitive Landscape
9.1. Overview
9.2. Market Share of Key Players in Global Digital Therapeutic (DTx) Market
9.2.1. Global Company Market Share
9.2.2. North America Company Market Share
9.2.3. Europe Company Market Share
9.2.4. APAC Company Market Share
9.3. Competitive Situations and Trends
9.3.1. Product Launches and Developments
9.3.2. Partnerships, Collaborations, and Agreements
9.3.3. Mergers & Acquisitions
9.3.4. Expansions
10. Company Profiles
10.1. Livongo Health
10.1.1. Business Overview
10.1.2. Company Snapshot
10.1.3. Company Market Share Analysis
10.1.4. Company Product Portfolio
10.1.5. Recent Developments
10.1.6. SWOT Analysis
10.2. WellDoc
10.2.1. Business Overview
10.2.2. Company Snapshot
10.2.3. Company Market Share Analysis
10.2.4. Company Product Portfolio
10.2.5. Recent Developments
10.2.6. SWOT Analysis
10.3. Proteus Digital Health
10.3.1. Business Overview
10.3.2. Company Snapshot
10.3.3. Company Market Share Analysis
10.3.4. Company Product Portfolio
10.3.5. Recent Developments
10.3.6. SWOT Analysis
10.4. Akili Interactive Labs
10.4.1. Business Overview
10.4.2. Company Snapshot
10.4.3. Company Market Share Analysis
10.4.4. Company Product Portfolio
10.4.5. Recent Developments
10.4.6. SWOT Analysis
10.5. Happify
10.5.1. Business Overview
10.5.2. Company Snapshot
10.5.3. Company Market Share Analysis
10.5.4. Company Product Portfolio
10.5.5. Recent Developments
10.5.6. SWOT Analysis
10.6. Mango Health
10.6.1. Business Overview
10.6.2. Company Snapshot
10.6.3. Company Market Share Analysis
10.6.4. Company Product Portfolio
10.6.5. Recent Developments
10.6.6. SWOT Analysis
10.7. Canary Health
10.7.1. Business Overview
10.7.2. Company Snapshot
10.7.3. Company Market Share Analysis
10.7.4. Company Product Portfolio
10.7.5. Recent Developments
10.7.6. SWOT Analysis
10.8. Cognoa
10.8.1. Business Overview
10.8.2. Company Snapshot
10.8.3. Company Market Share Analysis
10.8.4. Company Product Portfolio
10.8.5. Recent Developments
10.8.6. SWOT Analysis
10.9. Mindstrong Health
10.9.1. Business Overview
10.9.2. Company Snapshot
10.9.3. Company Market Share Analysis
10.9.4. Company Product Portfolio
10.9.5. Recent Developments
10.9.6. SWOT Analysis
10.10. Ginger
10.10.1. Business Overview
10.10.2. Company Snapshot
10.10.3. Company Market Share Analysis
10.10.4. Company Product Portfolio
10.10.5. Recent Developments
10.10.6. SWOT Analysis
10.11. Noom
10.11.1. Business Overview
10.11.2. Company Snapshot
10.11.3. Company Market Share Analysis
10.11.4. Company Product Portfolio
10.11.5. Recent Developments
10.11.6. SWOT Analysis
10.12. Pear Therapeutics
10.12.1. Business Overview
10.12.2. Company Snapshot
10.12.3. Company Market Share Analysis
10.12.4. Company Product Portfolio
10.12.5. Recent Developments
10.12.6. SWOT Analysis
10.13. Better Therapeutics
10.13.1. Business Overview
10.13.2. Company Snapshot
10.13.3. Company Market Share Analysis
10.13.4. Company Product Portfolio
10.13.5. Recent Developments
10.13.6. SWOT Analysis
10.14. Click Therapeutics
10.14.1. Business Overview
10.14.2. Company Snapshot
10.14.3. Company Market Share Analysis
10.14.4. Company Product Portfolio
10.14.5. Recent Developments
10.14.6. SWOT Analysis
10.15. Ayogo Health
10.15.1. Business Overview
10.15.2. Company Snapshot
10.15.3. Company Market Share Analysis
10.15.4. Company Product Portfolio
10.15.5. Recent Developments
10.15.6. SWOT Analysis
10.16. Omada Health
10.16.1. Business Overview
10.16.2. Company Snapshot
10.16.3. Company Market Share Analysis
10.16.4. Company Product Portfolio
10.16.5. Recent Developments
10.16.6. SWOT Analysis
10.17. Propeller Health
10.17.1. Business Overview
10.17.2. Company Snapshot
10.17.3. Company Market Share Analysis
10.17.4. Company Product Portfolio
10.17.5. Recent Developments
10.17.6. SWOT Analysis
10.18. Kaia Health
10.18.1. Business Overview
10.18.2. Company Snapshot
10.18.3. Company Market Share Analysis
10.18.4. Company Product Portfolio
10.18.5. Recent Developments
10.18.6. SWOT Analysis
10.19. Wellthy Therapeutics
10.19.1. Business Overview
10.19.2. Company Snapshot
10.19.3. Company Market Share Analysis
10.19.4. Company Product Portfolio
10.19.5. Recent Developments
10.19.6. SWOT Analysis
10.20. 2Morrow
10.20.1. Business Overview
10.20.2. Company Snapshot
10.20.3. Company Market Share Analysis
10.20.4. Company Product Portfolio
10.20.5. Recent Developments
10.20.6. SWOT Analysis
List of Table
1. Global Digital Therapeutic (DTx) Market, By Application, 2017–2027(USD Billion)
2. Global Gastrointestinal Disorder In Digital Therapeutic (DTx) Market, By Region, 2017–2027(USD Billion)
3. Global Smoking Cessation In Digital Therapeutic (DTx) Market, By Region, 2017–2027(USD Billion)
4. Global Respiratory Disease In Digital Therapeutic (DTx) Market, By Region, 2017–2027(USD Billion)
5. Global Central Nervous System Disease In Digital Therapeutic (DTx) Market, By Region, 2017–2027(USD Billion)
6. Global Cardiovascular Disease In Digital Therapeutic (DTx) Market, By Region, 2017–2027(USD Billion)
7. Global Obesity In Digital Therapeutic (DTx) Market, By Region, 2017–2027(USD Billion)
8. Global Diabetes In Digital Therapeutic (DTx) Market, By Region, 2017–2027(USD Billion)
9. Global Digital Therapeutic (DTx) Market, By Sales Channel, 2017–2027(USD Billion)
10. Global Business-to-Consumer, Digital Therapeutic (DTx) Market, By Region, 2017–2027(USD Billion)
11. Global Business-to-Business, Digital Therapeutic (DTx) Market, By Region, 2017–2027(USD Billion)
12. Global Digital Therapeutic (DTx) Market, By Region, 2017–2027(USD Billion)
13. Global Digital Therapeutic (DTx) Market, By North America, 2017–2027(USD Billion)
14. North America Digital Therapeutic (DTx) Market, By Application, 2017–2027(USD Billion)
15. North America Digital Therapeutic (DTx) Market, By Sales Channel, 2017–2027(USD Billion)
16. U.S. Digital Therapeutic (DTx) Market, By Application, 2017–2027(USD Billion)
17. U.S. Digital Therapeutic (DTx) Market, By Sales Channel, 2017–2027(USD Billion)
18. Canada Digital Therapeutic (DTx) Market, By Application, 2017–2027(USD Billion)
19. Canada Digital Therapeutic (DTx) Market, By Sales Channel, 2017–2027(USD Billion)
20. Mexico Digital Therapeutic (DTx) Market, By Application, 2017–2027(USD Billion)
21. Mexico Digital Therapeutic (DTx) Market, By Sales Channel, 2017–2027(USD Billion)
22. Europe Digital Therapeutic (DTx) Market, By Application, 2017–2027(USD Billion)
23. Europe Digital Therapeutic (DTx) Market, By Sales Channel, 2017–2027(USD Billion)
24. Germany Digital Therapeutic (DTx) Market, By Application, 2017–2027(USD Billion)
25. Germany Digital Therapeutic (DTx) Market, By Sales Channel, 2017–2027(USD Billion)
26. France Digital Therapeutic (DTx) Market, By Application, 2017–2027(USD Billion)
27. France Digital Therapeutic (DTx) Market, By Sales Channel, 2017–2027(USD Billion)
28. U.K. Digital Therapeutic (DTx) Market, By Application, 2017–2027(USD Billion)
29. U.K. Digital Therapeutic (DTx) Market, By Sales Channel, 2017–2027(USD Billion)
30. Italy Digital Therapeutic (DTx) Market, By Application, 2017–2027(USD Billion)
31. Italy Digital Therapeutic (DTx) Market, By Sales Channel, 2017–2027(USD Billion)
32. Spain Digital Therapeutic (DTx) Market, By Application, 2017–2027(USD Billion)
33. Spain Digital Therapeutic (DTx) Market, By Sales Channel, 2017–2027(USD Billion)
34. Asia Pacific Digital Therapeutic (DTx) Market, By Application, 2017–2027(USD Billion)
35. Asia Pacific Digital Therapeutic (DTx) Market, By Sales Channel, 2017–2027(USD Billion)
36. Japan Digital Therapeutic (DTx) Market, By Application, 2017–2027(USD Billion)
37. Japan Digital Therapeutic (DTx) Market, By Sales Channel, 2017–2027(USD Billion)
38. China Digital Therapeutic (DTx) Market, By Application, 2017–2027(USD Billion)
39. China Digital Therapeutic (DTx) Market, By Sales Channel, 2017–2027(USD Billion)
40. India Digital Therapeutic (DTx) Market, By Application, 2017–2027(USD Billion)
41. India Digital Therapeutic (DTx) Market, By Sales Channel, 2017–2027(USD Billion)
42. South America Digital Therapeutic (DTx) Market, By Application, 2017–2027(USD Billion)
43. South America Digital Therapeutic (DTx) Market, By Sales Channel, 2017–2027(USD Billion)
44. Brazil Digital Therapeutic (DTx) Market, By Application, 2017–2027(USD Billion)
45. Brazil Digital Therapeutic (DTx) Market, By Sales Channel, 2017–2027(USD Billion)
46. Middle East and Africa Digital Therapeutic (DTx) Market, By Application, 2017–2027(USD Billion)
47. Middle East and Africa Digital Therapeutic (DTx) Market, By Sales Channel, 2017–2027(USD Billion)
48. UAE Digital Therapeutic (DTx) Market, By Application, 2017–2027(USD Billion)
49. UAE Digital Therapeutic (DTx) Market, By Sales Channel, 2017–2027(USD Billion)
50. South Africa Digital Therapeutic (DTx) Market, By Application, 2017–2027(USD Billion)
51. South Africa Digital Therapeutic (DTx) Market, By Sales Channel, 2017–2027(USD Billion)
List of Figures
1. Global Digital Therapeutic (DTx) Market Segmentation
2. Digital Therapeutic (DTx) Market: Research Methodology
3. Market Size Estimation Methodology: Bottom-Up Approach
4. Market Size Estimation Methodology: Top-Down Approach
5. Data Triangulation
6. Porter’s Five Forces Analysis
7. Value Chain Analysis
8. Global Digital Therapeutic (DTx) Market Attractiveness Analysis By Application
9. Global Digital Therapeutic (DTx) Market Attractiveness Analysis By Sales Channel
10. Global Digital Therapeutic (DTx) Market Attractiveness Analysis By Region
11. Global Digital Therapeutic (DTx) Market: Dynamics
12. Global Digital Therapeutic (DTx) Market Share By Application (2019 & 2027)
13. Global Digital Therapeutic (DTx) Market Share By Sales Channel (2019 & 2027)
14. Global Digital Therapeutic (DTx) Market Share by Regions (2019 & 2027)
15. Global Digital Therapeutic (DTx) Market Share by Company (2019)
Market research is a method of gathering, assessing and deducing data & information about a particular market. Market research is very crucial in these days. The techniques analyze about how a product/service can be offered to the market to its end-customers, observe the impact of that product/service based on the past customer experiences, and cater their needs and demands. Owing to the successful business ventures, accurate, relevant and thorough information is the base for all the organizations because market research report/study offers specific market related data & information about the industry growth prospects, perspective of the existing customers, and the overall market scenario prevailed in past, ongoing present and developing future. It allows the stakeholders and investors to determine the probability of a business before committing substantial resources to the venture. Market research helps in solving the marketing issues challenges that a business will most likely face.
Market research is valuable because of the following reasons:
Our research report features both the aspects; qualitative and quantitative. Qualitative part provides insights about the market driving forces, potential opportunities, customer’s demands and requirement which in turn help the companies to come up with new strategies in order to survive in the long run competition. The quantitative segment offers the most credible information related to the industry. Based on the data gathering, we use to derive the market size and estimate their future growth prospects on the basis of global, region and country.
Our market research process involves with the four specific stages.
Data Collection: This stage of the market research process involves with the gathering and collecting of the market/industry related data from the sources. There are basically two types of research methods:
Data Synthesis: This stage includes the evaluation and assessment of all the data acquired from the primary and secondary research. It likewise includes in evaluating the information for any disparity watched while information gathering identified with the market. The data & information is gathered with consideration to the heterogeneity of sources. Scientific and statistical methods are implemented for synthesizing dissimilar information sets and provide the relevant data which is fundamental for formulating strategies. Our organization has broad involvement with information amalgamation where the information goes through different stages:
Market Formulation & Deduction: The last stage includes assigning the data & information in a suitable way in order to derive market size. Analyst reviews and domain based opinions based on holistic approach of market estimation combined with industry investigation additionally features a crucial role in this stage.
This stage includes with the finalization of the market size and numbers that we have gathered from primary and secondary research. With the data & information addition, we ensure that there is no gap in the market information. Market trend analysis is finished by our analysts by utilizing data extrapolation procedures, which give the most ideal figures to the market.
Data Validation: Validation is the most crucial step in the process. Validation & re-validation through scientifically designed technique and process that helps us finalize data-points to be used for final calculations. This stage also involves with the data triangulation process. Data triangulation generally implicates the cross validation and matching the data which has been collected from primary and secondary research methods.
Free Customization
Countries can be added on demand
Free yearly update on purchase of Multi/Corporate User License
Companies served till date
We serve our customers 24x7 for 365 days through calls, emails and live chat options.
Huge database of exceptional market reports bringing market intelligence to your fingertips.
SSL enabled, we offer you various secured payment options for risk free purchase.